Search

everythinglearnresearchcommunity

for

Search:↓

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Activating Notch in adult skin causes T cells and neural crest cells to gather, leading to skin issues.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

BAF200 is essential for proper heart and coronary artery formation.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Somatostatin may help protect hair follicles from immune attacks.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.